CRADA-Cooperative Research & Development Agreement

COMBINED PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDIES EVALUATING THE EFFICACY AND SAFETY OF FILGOTINIB IN THE INDUCTION AND MAINTENANCE OF REMISSION IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE (895)

MAJOR EXTREMITY TRAUMA RESEARCH CONSORTIUM (METRC) – EARLY ADVANCED WEIGHT BEARING FOR PERI-ARTICULAR KNEE AND PILON INJURIES: AN RTC USING THE ANTI-GRAVITY TREADMILL (ALTERG)

MAJOR EXTREMITY TRAUMA RESEARCH CONSORTIUM (METRC) IMPROVING RECOVERY AFTER ORTHOPAEDIC TRAUMA: COGNITIVE-BEHAVIORAL BASED PHYSICAL THERAPY (CBPT)

A PROSPECTIVE STUDY OF EARLY MECHANICAL STABILIZATION AND BLEEDING IN DISRUPTION OF THE PELVIC RING

DEVELOPMENT OF A SELF-REPORT INSTRUMENT FOR HIGH MOBILITY PROSTHESIS USERS: VALIDATION STUDY

UNIVERSITY OF WASHINGTON

CRADA-Cooperative Research & Development Agreement

STELLARIS: A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CENICRIVIROC FOR THE TREATMENT OF LIVER FIBROSIS IN ADULT SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS

NEEDS, PREFERENCES AND FUNCTIONAL ABILITIES OF VETERANS AND SERVICE MEMBERS WITH UPPER LIMB AMPUTATION

CRADA-Cooperative Research & Development Agreement

A PHASE 3, MULTICENTER, OPEN-LABEL EXTENSION STUDY OF ORAL OZANIMOD FOR MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

CRADA-Cooperative Research & Development Agreement

A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ORAL OZANIMOD AS MAINTENANCE THERAPY FOR MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

CRADA-Cooperative Research & Development Agreement

ROMAN: REDUCTION IN ORAL MUCOSITIS WITH AVASOPASEM MANGANESE (GC4419) – PHASE 3 TRIAL IN PATIENTS RECEIVING CHEMORADIOTHERAPY FOR LOCALLY-ADVANCED, NON-METASTATIC HEAD AND NECK CANCER

GALERA THERAPEUTICS, INC.

CRADA-Cooperative Research & Development Agreement

A PHASE 3, MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF CSL112 IN SUBJECTS WITH ACUTE CORONARY SYNDROME

CRADA-Cooperative Research & Development Agreement

A PHASE 3, MULTINATIONAL, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF MGL-3196 (RESMETIROM) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) TO RESOLVE NASH AND REDUCE PROGRESSION TO CIRRHOSIS AND/OR HEPATIC DECOMPENSATION

MADRIGAL PHARMACEUTICALS, INC

ULTRASOUND-GUIDED PERCUTANEOUS PERIPHERAL NERVE STIMULATION: A NON-PHARMACOLOGIC ALTERNATIVE FOR THE TREATMENT OF POSTOPERATIVE PAIN.

UNIVERISTY OF CALIFORNIA

CRADA-Cooperative Research & Development Agreement

A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ELAFIBRANOR IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) AND FIBROSIS

CRADA-Cooperative Research & Development Agreement

ECO-RESET: A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE DOSE, MULTICENTER STUDY TO ASSESS EFFICACY AND SAFETY OF SER‑287 IN ADULTS WITH ACTIVE MILD-TO-MODERATE ULCERATIVE COLITIS

SERES THERAPEUTICS, INC.

CRADA-Cooperative Research & Development Agreement

THE AIM-HN AND SEQ-HN STUDY: A 2 COHORT, NON-COMPARATIVE, PIVOTAL STUDY EVALUATING THE EFFICACY OF TIPIFARNIB IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) WITH HRAS MUTATIONS (AIM-HN) AND THE IMPACT OF HRAS MUTATIONS ON RESPONSE TO FIRST LINE SYSTEMIC THERAPIES FOR HNSCC (SEQ-HN)

CRADA-Cooperative Research & Development Agreement

INDUCTION STUDY #2 - A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ORAL OZANIMOD AS INDUCTION THERAPY FOR MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

CRADA-Cooperative Research & Development Agreement

CRADA-Cooperative Research & Development Agreement

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE

UNIVERSITY OF WASHINGTON

CRADA-Cooperative Research & Development Agreement

DCI - DEPARTMENT OF CLINICAL INVESTIGATION

GYPSY BAY GENOMICS

CRADA-Cooperative Research & Development Agreement

A RANDOMIZED, MULTICENTER, OPEN-LABEL, PHASE 3 STUDY TO COMPARE THE EFFICACY AND SAFETY OF ACALABRUTINIB (ACP-196) IN COMBINATION WITH VENETOCLAX WITH AND WITHOUT OBINUTUZUMAB COMPARED TO INVESTIGATOR’S CHOICE OF CHEMOIMMUNOTHERAPY IN SUBJECTS WITH PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA WITHOUT DEL(17P) OR TP53 MUTATION

CRADA-Cooperative Research & Development Agreement

ECOSPOR III: A PHASE 3 MULTICENTER, RANDOMIZEED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF SER-109 VS. PLACEBO TO REDUCE RECURRENCE OF CLOSTRIDIUM DIFFICILE INFECTION (CDI) IN ADULTS WHO HAVE RECEIVED ANTIBACTERIAL DRUG TREATMENT FOR RECURRENT CDI (RCDI). SHORT TITLE: "SERES-012."

SERES THERAPEUTICS, INC.

CRADA-Cooperative Research & Development Agreement

A PHASE 2, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, MULTIPLE CENTER STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF NGM282 ADMINISTERED FOR 12 WEEKS IN PATIENTS WITH HISTOLOGICALLY CONFIRMED NON-ALCOHOLIC STEATOHEPATITIS (NASH)

NGM BIOPHARMACEUTICALS AUSTRALIA PTY LTD.

CRADA-Cooperative Research & Development Agreement

STRATEGIC MANAGEMENT TO IMPROVE CRT USING MULTI-SITE PACING POST APPROVAL STUDY

CRADA-Cooperative Research & Development Agreement

A PROSTHETIC FOOT EMULATOR TO OPTIMIZE PRESCRIPTION OF PROSTHETIC FEET IN VETERANS AND SERVICE MEMBERS WITH LEG AMPUTATIONS

US ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY

CRADA-Cooperative Research & Development Agreement

ENTYVIO (VEDOLIZUMAB) LONG-TERM SAFETY STUDY: AN INTERNATIONAL OBSERVATIONAL PROSPECTIVE COHORT STUDY COMPARING VEDOLIZUMAB TO OTHER BIOLOGIC AGENTS IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN’S DISEASE

TAKEDA GLOBAL RESEARCH

CRADA-Cooperative Research & Development Agreement

DECREASING SUICIDE RISK AMONG SERVICE MEMBERS WITH POSTTRAUMATIC STRESS USING WRITTEN EXPOSURE THERAPY

CRADA-Cooperative Research & Development Agreement

TARGETING CHRONIC PAIN IN PRIMARY CARE SETTINGS USING INTERNAL BEHAVIORAL HEALTH CONSULTANTS

CRADA-Cooperative Research & Development Agreement

TREATMENT PATTERNS, OUTCOMES, AND PATIENT-REPORTED HEALTH-RELATED QUALITY OF LIFE: A PROSPECTIVE DISEASE REGISTRY OF PATIENTS WITH MANTLE CELL LYMPHOMA TREATED WITH NOVEL AGENTS

ASTRAZENECA PHARMACEUTICALS

DRM - BRAIN INJURY REHABILITATION SERVICE

LUNG ULTRASOUND WITH NEURAL-NET GENERATED POINT-OF-CARE IDENTIFICATION OF INJURY TRIAL (LUNG-POINT)

UNIFORMED SERVICES UNIVERSITY OF HEALTH SCIENCES

CRADA-Cooperative Research & Development Agreement

A PHASE 3, RANDOMIZED, STUDY TO ASSESS THE EFFICACY AND SAFETY OF UBLITUXIMAB IN COMBINATION WITH IBRUTINIB COMPARED TO IBRUTINIB ALONE, IN PATIENTS WITH PREVIOUSLY TREATED HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

CRADA-Cooperative Research & Development Agreement

A PHASE III STUDY OF BBI-608 IN COMBINATION WITH 5-FLUOROURACIL, LEUCOVORIN, IRINOTECAN (FOLFIRI) IN ADULT PATIENTS WITH PREVIOUSLY TREATED METASTATIC COLORECTAL CANCER (CRC)

CRADA-Cooperative Research & Development Agreement

A PHASE 2, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, MULTIPLE CENTER STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF NGM282 ADMINISTERED FOR 12 WEEKS IN PATIENTS WITH HISTOLOGICALLY CONFIRMED NON-ALCOHOLIC STEATOHEPATITIS (NASH)

NGM BIOPHARMACEUTICALS AUSTRALIA PTY LTD.

CRADA-Cooperative Research & Development Agreement

APIXABAN FOR THE REDUCTION OF THROMBO-EMBOLISM IN PATIENTS WITH DEVICE-DETECTED SUB-CLINICAL ATRIAL FIBRILLATION

HAMILTON HEALTH SCIENCES

CRADA-Cooperative Research & Development Agreement

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY TO ASSESS CARDIOVASCULAR OUTCOMES FOLLOWING TREATMENT WITH ERTUGLIFLOZIN (MK-8835/PF-04971729) IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED VASCULAR DISEASE

CRADA-Cooperative Research & Development Agreement

A LONG-TERM EXTENSION STUDY TO EVALUATE THE SAFETY OF FILGOTINIB IN SUBJECTS WITH CROHN’S DISEASE." SHORT TITLE: "GS-US-419-3896."

CRADA-Cooperative Research & Development Agreement

A LONG TERM-EXTENSION STUDY TO EVALUATE THE SAFETY OF FILGOTINIB IN SUBJECTS WITH ULCERATIVE COLITIS

ASSESSING REHABILITATION OUTCOMES AFTER SEVERE NEUROMUSCULOSKELETAL INJURY: DEVELOPMENT OF PATIENT REPORTED OUTCOMES ASSESSMENT INSTRUMENTS

DATA SHARING AGREEMENT BETWEEN THE JOINT PATHOLOGY CENTER (JPC)AND BROOKE ARMY MEDICAL CENTER (BAMC) FOR ACTUR DATA SHARING AGREEMENT FOR RESEARCH PROTOCOL

JOINT PATHOLOGY CENTER

CRADA-Cooperative Research & Development Agreement

OTTO BOCK HEALTHCARE GMBH

CRADA-Cooperative Research & Development Agreement

A PHASE 2B RANDOMIZED STUDY TO ASSESS THE EFFICACY AND SAFETY OF THE COMBINATION OF UBLITUXIMAB + TGR-1202 WITH OR WITHOUT BENDAMUSTINE AND TGR-1202 ALONE IN PATIENTS WITH PREVIOUSLY TREATED NON-HODGKIN’S LYMPHOMA." SHORT TITLE: "UTX-TGR-205

CRADA-Cooperative Research & Development Agreement

A PHASE 3, DOUBLE-BLIND, RANDOMIZED, LONG-TERM, PLACEBO-CONTROLLED, MULTICENTER STUDY EVALUATING THE SAFETY AND EFFICACY OF OBETICHOLIC ACID IN SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS.

INTERCEPT PHARMACEUTICALS, INC

CRADA-Cooperative Research & Development Agreement

BLOOD SAMPLE COLLECTION TO EVALUATE BIOMARKERS IN SUBJECTS WITH UNTREATED SOLID TUMORS

EXACT SCIENCES CORPORATION

CRADA-Cooperative Research & Development Agreement

A SINGLE COHORT PHASE 4 TRIAL INVESTIGATING THE IMPACT OF G-CSF PRIMARY PROPHYLAXIS FOR ADVANCED STAGE HODGKIN LYMPHOMA PATIENTS TREATED WITH A+AVD

CRADA-Cooperative Research & Development Agreement

A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE DUMMY, PARALLEL GROUP, ACTIVE-CONTROLLED 8-WEEK STUDY TO EVALUATE THE EFFECT OF SACUBITRIL AND VALSARTAN (LCZ696) VERSUS ENALAPRIL ON CHANGES IN NT-PROBNP AND SAFETY AND TOLERABILITY OF IN-HOSPITAL INITIATION OF LCZ696 COMPARED TO ENALAPRIL IN HFREF PATIENTS WHO HAVE BEEN STABILIZED FOLLOWING HOSPITALIZATION FOR ACUTE DECOMPENSATED HEART FAILURE (ADHF).

NOVARTIS PHARMACEUTICALS

CRADA-Cooperative Research & Development Agreement

AN OPEN-LABEL, 2 X 2 FACTORIAL, RANDOMIZED CONTROLLED, CLINICAL TRIAL TO EVALUATE THE SAFETY OF APIXABAN VS. VITAMIN K ANTAGONIST AND ASPIRIN VS. ASPIRIN PLACEBO IN SUBJECTS WITH ATRIAL FIBRILLATION AND ACUTE CORONARY SYNDROME OR PERCUTANEOUS CORONARY INTERVENTION

BRISTOL-MYERS SQUIBB COMPANY

CRADA-Cooperative Research & Development Agreement

A PHASE 2B, PROSPECTIVE, DOUBLE-BLINDED, RANDOMIZED CONTROLLED TRAIL OF THE MICRONIZED DHACM INJECTION AS COMPARED TO SALINE PLACEBO INJECTION THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE

CRADA-Cooperative Research & Development Agreement

A PHASE 3, MULTICENTER, OPEN-LABEL EXTENSION TRIAL OF ORAL RPC1063 AS THERAPY FOR MODERATE TO SEVERE ULCERATIVE COLITIS

CRADA-Cooperative Research & Development Agreement

A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ORAL RPC1063 AS INDUCTION AND MAINTENANCE THERAPY FOR MODERATE TO SEVERE ULCERATIVE COLITIS.” SHORT TITLE: “RPC01-3101"

CRADA-Cooperative Research & Development Agreement

A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF FILGOTINIB IN THE TREATMENT OF PERIANAL FISTULIZING CROHN’S DISEASE

VALIDATION OF THE START BACK SCREENING TOOL IN PRIMARY CARE MANAGEMENT OF BACK PAIN IN THE MILITARY HEALTH SYSTEM: A RANDOMIZED TRIAL OF RISK-STRATIFIED CARE

SEATTLE VA MED CENTER

CRADA-Cooperative Research & Development Agreement

SENTIER STRATEGIC RESOURCES, LLC

EXPLORING THE VALUE OF THE DOD/VA CLINICAL PRACTICE GUIDELINES FOR NON-SURGICAL MANAGEMENT OF KNEE OSTEOARTHRITIS IN THE MILITARY HEALTH SYSTEM

CRADA-Cooperative Research & Development Agreement

CORE-SCORE PHASE 1: IMPLEMENTATION OF A BRIEF COGNITIVE REHABILITATION INTERVENTION TO ENHANCE EFFICIENCY OF SERVICE DELIVERY FOR SERVICE MEMBERS AND VETERANS WITH MTBI

DRM - BRAIN INJURY REHABILITATION SERVICE

CRADA-Cooperative Research & Development Agreement

INDUCTION STUDY #2 - A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ORAL OZANIMOD AS INDUCTION THERAPY FOR MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

CRADA-Cooperative Research & Development Agreement

A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF EMRICASAN, AN ORAL CASPASE INHIBITOR, IN SUBJECTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) CIRRHOSIS AND SEVERE PORTAL HYPERTENSION

CONATUS PHARMACEUTICALS

CRADA-Cooperative Research & Development Agreement

A RANDOMIZED, CONTROLLED, OPEN-LABEL, GLOBAL PHASE 3 STUDY COMPARING THE EFFICACY OF THE ANTI-PD-1 ANTIBODY BGB-A317 VERSUS CHEMOTHERAPY AS SECOND LINE TREATMENT IN PATIENTS WITH ADVANCED UNRESECTABLE/METASTATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA." SHORT TITLE: "BGB-A317-302

CRADA-Cooperative Research & Development Agreement

EVALUATING THE DIAGNOSTIC PERFORMANCE OF NEAR INFRARED SPECTROSCOPY (NIRS) IN THE SETTING OF ACUTE COMPARTMENT SYNDROME (ACS) IN TRAUMATIZED LOWER EXTREMITIE

CRADA-Cooperative Research & Development Agreement

UNIFORMED SERVICES UNIVERSITY OF HEALTH SCIENCES

TRI-NURSING

CRADA-Cooperative Research & Development Agreement

A RANDOMIZED PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ENZASTAURIN PLUS R-CHOP VERSUS R-CHOP IN TREATMENT-NAÏVE SUBJECTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA WHO POSSESS THE NOVEL GENOMIC BIOMARKER DGM1 (“CLINICAL STUDY”)

ULTRASOUND DETECTION OF PNEUMOTHORAX BY MILITARY MEDICS PREVIOUSLY NAÏVE TO SONOGRAPHY. A SINGLE-BLINDED CROSS-SECTIONAL STUDY DESIGN USING CADAVER MODELS

FUJIFILM SONOSITE

CRADA-Cooperative Research & Development Agreement

TELEHEALTH 2.0: PRESERVING CONTINUITY OF BEHAVIORAL HEALTH CLINICAL CARE TO PATIENTS USING MOBILE DEVICES

CRADA-Cooperative Research & Development Agreement

A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ORAL RPC1063 AS INDUCTION AND MAINTENANCE THERAPY FOR MODERATE TO SEVERE ULCERATIVE COLITIS.” SHORT TITLE: “RPC01-3101"

CRADA-Cooperative Research & Development Agreement

PATTERNS OF HEALTHCARE UTILIZATION AFTER MUSCULOSKELETAL INJURIES OF THE SPINE AND UPPER EXTREMITY IN THE MHS

DUKE UNIVERSITY

CRADA-Cooperative Research & Development Agreement

DUKE UNIVERSITY

CRADA-Cooperative Research & Development Agreement

A PHASE III STUDY OF BBI-608 IN COMBINATION WITH 5-FLUOROURACIL, LEUCOVORIN, IRINOTECAN (FOLFIRI) IN ADULT PATIENTS WITH PREVIOUSLY TREATED METASTATIC COLORECTAL CANCER (CRC)

CRADA-Cooperative Research & Development Agreement

A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OBETICHOLIC ACID IN SUBJECTS WITH COMPENSATED CIRRHOSIS DUE TO NONALCOHOLIC STEATOHEPATITIS

INTERCEPT PHARMACEUTICALS, INC

CRADA-Cooperative Research & Development Agreement

TRAUMA OUTCOMES AND UROGENITAL HEALTH IN OEF/OIF (TOUGH) – A RETROSPECTIVE COHORT STUDY WITH LONG-TERM FOLLOW-UP

CRADA-Cooperative Research & Development Agreement

A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF OMECAMTIV MECARBIL ON MORTALITY AND MORBIDITY IN SUBJECTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION

CRADA-Cooperative Research & Development Agreement

A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, ACTIVE-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LCZ696 COMPARED TO VALSARTAN, ON MORBIDITY AND MORTALITY IN HEART FAILURE PATIENTS (NYHA CLASS II-IV) WITH PRESERVED EJECTION FRACTION

NOVARTIS PHARMACEUTICALS CORP.

CRADA-Cooperative Research & Development Agreement

A PROSPECTIVE NON-INVASIVE STUDY OF CEREBRAL BLOOD FLOW VELOCITY MORPHOLOGY FOR QUANTIFICATION OF INTRACRANIAL PRESSURE

CRADA-Cooperative Research & Development Agreement

STUDY TO EVALUATE THE EFFECT OF DAPAGLIFLOZIN ON THE INCIDENCE OF WORSENING HEART FAILURE OR CARDIOVASCULAR DEATH IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION

ASTRAZENECA PHARMACEUTICALS

CRADA-Cooperative Research & Development Agreement

ESTABLISHMENT OF A TISSUE REPOSITORY FOR THE MURTHA CANCER CENTER BIOBANK (MCCB) AT BAMC

UNIFORMED SERVICES UNIVERSITY OF HEALTH SCIENCES

CRADA-Cooperative Research & Development Agreement

PATTERN OF USE AND SAFETY/EFFECTIVENESS OF NIVOLUMAB IN ROUTINE ONCOLOGY PRACTICE

BRISTOL-MYERS SQUIBB COMPANY

CRADA-Cooperative Research & Development Agreement

A PATIENT TOOLKIT FOR THE TRANSITION OF CARE OF ACTIVE DUTY PATIENTS WITH IBD TO THE VETERANS ADMINISTRATION HEALTHCARE SYSTEM

AMERICAN COLLEGE OF GASTROENTEROLOGY

CRADA-Cooperative Research & Development Agreement

A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF FILGOTINIB IN THE TREATMENT OF PERIANAL FISTULIZING CROHN’S DISEASE

CRADA-Cooperative Research & Development Agreement

A PHASE 3, MULTICENTER, OPEN-LABEL EXTENSION TRIAL OF ORAL RPC1063 AS THERAPY FOR MODERATE TO SEVERE ULCERATIVE COLITIS

CRADA-Cooperative Research & Development Agreement

ECOSPOR IV: AN OPEN-LABEL EXTENSION OF STUDY SERES-012 EVALUATING SER-109 IN ADULT SUBJECTS WITH RECURRENT CLOSTRIDIUM DIFFICILE INFECTION (RCDI). SHORT TITLE: "SERES-013."

SERES THERAPEUTICS, INC.

CRADA-Cooperative Research & Development Agreement

A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF OMECAMTIV MECARBIL ON MORTALITY AND MORBIDITY IN SUBJECTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION

CRADA-Cooperative Research & Development Agreement

OTTO BOCK HEALTHCARE GMBH

CRADA-Cooperative Research & Development Agreement

DCI - DEPARTMENT OF CLINICAL INVESTIGATION

CRADA-Cooperative Research & Development Agreement

A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ORAL RPC1063 AS INDUCTION AND MAINTENANCE THERAPY FOR MODERATE TO SEVERE ULCERATIVE COLITIS.” SHORT TITLE: “RPC01-3101"

CRADA-Cooperative Research & Development Agreement

“A MULTINATIONAL, MULTICENTER, RANDOMIZED, PHASE 3 STUDY OF TESETAXEL PLUS A REDUCED DOSE OF CAPECITABINE VERSUS CAPECITABINE ALONE IN PATIENTS WITH HER2 NEGATIVE, HORMONE RECEPTOR POSITIVE, LOCALLY ADVANCED OR METASTATIC BREAST CANCER PREVIOUSLY TREATED WITH A TAXANE”. SHORT TITLE, “ODENATE 2018.023”

ODONATE THERAPEUTICS LLC

CRADA-Cooperative Research & Development Agreement

STELLARIS: A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CENICRIVIROC FOR THE TREATMENT OF LIVER FIBROSIS IN ADULT SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS

CRADA-Cooperative Research & Development Agreement

EFFICACY STUDY OF INECALCITOL IN COMBINATION WITH DECITABINE IN ACUTE MYELOID LEUKEMIA PATIENTS UNFIT FOR STANDARD CHEMOTHERAPY

CRADA-Cooperative Research & Development Agreement

COMBINED PHASE 2B/3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDIES EVALUATING THE EFFICACY AND SAFETY OF FILGOTINIB IN THE INDUCTION AND MAINTENANCE OF REMISSION IN SUBJECTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

LUNG ULTRASOUND WITH NEURAL-NET GENERATED POINT-OF-CARE IDENTIFICATION OF INJURY TRIAL (LUNG-POINT)

INVENTIVE GOVERNMENT SOLUTIONS, LLC

CRADA-Cooperative Research & Development Agreement

ENTYVIO (VEDOLIZUMAB) LONG-TERM SAFETY STUDY: AN INTERNATIONAL OBSERVATIONAL PROSPECTIVE COHORT STUDY COMPARING VEDOLIZUMAB TO OTHER BIOLOGIC AGENTS IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN’S DISEASE

TAKEDA GLOBAL RESEARCH

CRADA-Cooperative Research & Development Agreement

A PHASE 3 STUDY COMPARING DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE (DRD) VS LENALIDOMIDE AND DEXAMETHASONE (RD) IN SUBJECTS WITH PREVIOUSLY UNTREATED MULTIPLE MYELOMA WHO ARE INELIGIBLE FOR HIGH DOSE THERAPY

JANSSEN RESEARCH & DEVELOPMENT LLC

WESTMEAD INSTITUTE FOR MEDICAL RESEARCH

MULTI-INSTITUTIONAL, PROSPECTIVE STUDY OF DIRECT SINGLE-STAGE IMPLANTATION OF SACRAL NEUROMODULATION

LOMA LINDA UNIVERSITY MED CTR

CRADA-Cooperative Research & Development Agreement

A PHASE 2, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, MULTIPLE CENTER STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFICACY OF NGM282 ADMINISTERED FOR 12 WEEKS IN PATIENTS WITH HISTOLOGICALLY CONFIRMED NON-ALCOHOLIC STEATOHEPATITIS (NASH)

NGM BIOPHARMACEUTICALS AUSTRALIA PTY LTD.

HEALTH RESEARCHTX LLC

CRADA-Cooperative Research & Development Agreement

A LONG-TERM EXTENSION STUDY TO EVALUATE THE SAFETY OF FILGOTINIB IN SUBJECTS WITH CROHN’S DISEASE." SHORT TITLE: "GS-US-419-3896."

CRADA-Cooperative Research & Development Agreement

A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF EMRICASAN, AN ORAL CASPASE INHIBITOR, IN SUBJECTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) CIRRHOSIS AND SEVERE PORTAL HYPERTENSION SHORT TITLE: "IDN-6556-14"

CONATUS PHARMACEUTICALS

CRADA-Cooperative Research & Development Agreement

A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF EMRICASAN, AN ORAL CASPASE INHIBITOR, IN SUBJECTS WITH DECOMPENSATED NON-ALCOHOLIC STEATOHEPATITIS (NASH) CIRRHOSIS" SHORT TITLE: "IDN-6556-17"

CONATUS PHARMACEUTICALS